Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.
Furler J, O'Neal DN, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Browne JL, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins AJ, Liew D, Clarke P, Best J. Furler J, et al. BMJ Open. 2018 Jul 17;8(7):e021435. doi: 10.1136/bmjopen-2017-021435. BMJ Open. 2018. PMID: 30018097 Free PMC article.
Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial.
Thuraisingam S, Chondros P, Catchpool M, Dalziel K, Manski-Nankervis JA, Speight J, Holmes-Truscott E, Audehm R, Chiang J, Blackberry I, O'Neal D, Khunti K, Best J, Furler J. Thuraisingam S, et al. Trials. 2019 Jan 30;20(1):93. doi: 10.1186/s13063-018-3126-1. Trials. 2019. PMID: 30700324 Free PMC article.
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J, O'Neal D, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Doyle R, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins A, Lake AJ, Januszewski AS, Catchpool M, Liew D, Clarke P, Best J. Furler J, et al. Lancet Diabetes Endocrinol. 2020 Jan;8(1):17-26. doi: 10.1016/S2213-8587(19)30385-7. Lancet Diabetes Endocrinol. 2020. PMID: 31862147 Clinical Trial.
18 results